Compare Fidelity National Information Servcs Inc (FIS) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fidelity National Information Servcs Inc vs TransMedics Group Inc — how do they compare? Fidelity National Information Servcs Inc trades at $44.4 (market cap $21.62B), while TransMedics Group Inc trades at $89.43 (market cap $3.02B). The key difference: Fidelity National Information Servcs Inc is far larger — about 7.2× TransMedics Group Inc's market cap, and Fidelity National Information Servcs Inc pays a 4.2% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| FIS | TMDX | |
|---|---|---|
Market Cap | $21.62B | $3.02B |
Sector | Technology | Technology |
52-Week High | $72.77 | $150.42 |
52-Week Low | $37.72 | $61.99 |
Enterprise Value | $42.13B | $3.41B |
Dividend Yield | 4.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIS trades at $44.13, up 3.2% today, with strong analyst support (58% buy ratings) and a $50.18 consensus price target suggesting 14% upside. The stock shows improving fundamentals with Q2 2026 earnings beating estimates at $1.48 per share and revenue growth accelerating to 5.3% pro forma. Technical indicators remain bearish despite recent gains, with the price testing key support at $42.
The outlook is cautiously optimistic with Banking Solutions driving growth and expanding margins, though Capital Markets weakness prompted a lowered full-year outlook. Key risks include execution on global expansion and competitive pressures in fintech. The attractive 6.4x P/E ratio and 27.6% net margin projection for 2026 support the bullish analyst stance.
TransMedics Group (TMDX) trades at $87.02, down 2.62% on the day, amid mixed earnings performance. The stock shows strong profitability with a 22.69% net margin and 36.28% ROE, but recent quarters saw misses on EPS expectations. Technicals are bullish with moving averages supporting upside, while oscillators signal caution. Recent news highlights an ongoing legal investigation into fiduciary duties by company directors.
The outlook is cautiously optimistic with a consensus price target of $99.57 implying 14% upside, supported by bullish analyst ratings. Key risks include earnings volatility, rising costs impacting margins, and potential legal overhangs from the fiduciary investigation. Revenue growth remains a positive catalyst, but investors should monitor execution against future guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Read more on FIS →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
